(1R,3S,5R,7R,8aS)-7-Ethylhexahydro-1-(6-hydroxy-4-quinolinyl)-3,7-methano-1H-pyrrolo[2,1-c][1,4]oxazine
≥98%(HPLC)
- Product Code: 84785
CAS:
1476067-44-3
| Molecular Weight: | 310.40 g./mol | Molecular Formula: | C₁₉H₂₂N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry |
Product Description:
This chemical is primarily utilized in the field of medicinal chemistry, where it serves as a key intermediate in the synthesis of complex pharmaceutical compounds. Its unique structure, featuring a fused oxazine and pyrrolo ring system, makes it valuable for developing drugs that target specific biological pathways.
One of its notable applications is in the creation of potential therapeutic agents for treating neurological disorders. The compound's ability to interact with neurotransmitter receptors in the brain makes it a promising candidate for developing medications aimed at managing conditions such as anxiety, depression, and cognitive impairments.
Additionally, its quinoline moiety contributes to its potential use in designing antimalarial drugs. The structural features of this chemical allow it to interfere with the life cycle of malaria parasites, offering a pathway for developing new treatments against drug-resistant strains of the disease.
Researchers also explore its utility in oncology, where it may be incorporated into drug candidates designed to inhibit specific enzymes or proteins involved in cancer cell proliferation. Its complex architecture enables precise modifications to enhance efficacy and reduce side effects in cancer therapies.
Overall, this chemical plays a significant role in advancing drug discovery and development across various therapeutic areas.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Very pale yellow - Pale reddish yellow Crystal - Powder |
| PURITY | 98-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.025 | 10-20 days | ฿9,950.00 |
+
-
|
(1R,3S,5R,7R,8aS)-7-Ethylhexahydro-1-(6-hydroxy-4-quinolinyl)-3,7-methano-1H-pyrrolo[2,1-c][1,4]oxazine
This chemical is primarily utilized in the field of medicinal chemistry, where it serves as a key intermediate in the synthesis of complex pharmaceutical compounds. Its unique structure, featuring a fused oxazine and pyrrolo ring system, makes it valuable for developing drugs that target specific biological pathways.
One of its notable applications is in the creation of potential therapeutic agents for treating neurological disorders. The compound's ability to interact with neurotransmitter receptors in the brain makes it a promising candidate for developing medications aimed at managing conditions such as anxiety, depression, and cognitive impairments.
Additionally, its quinoline moiety contributes to its potential use in designing antimalarial drugs. The structural features of this chemical allow it to interfere with the life cycle of malaria parasites, offering a pathway for developing new treatments against drug-resistant strains of the disease.
Researchers also explore its utility in oncology, where it may be incorporated into drug candidates designed to inhibit specific enzymes or proteins involved in cancer cell proliferation. Its complex architecture enables precise modifications to enhance efficacy and reduce side effects in cancer therapies.
Overall, this chemical plays a significant role in advancing drug discovery and development across various therapeutic areas.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :